The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
The microbiota control regional immunity using mechanisms such as inducing IL-17A-producing γδ T (γδT-17) cells in various tissues. However, little is known regarding hepatic γδT cells that are constantly stimulated by gut commensal microbes. Here we show hepatic γδT cells are liver-resident cells and predominant producers of IL-17A. The microbiota sustain hepatic γδT-17 cell homeostasis, including activation, survival and proliferation. The global commensal quantity affects the number of liver-resident γδT-17 cells; indeed, E. coli alone can generate γδT-17 cells in a dose-dependent manner. Liver-resident γδT-17 cell homeostasis depends on hepatocyte-expressed CD1d, that present lipid antigen, but not Toll-like receptors or IL-1/IL-23 receptor signalling. Supplementing mice in vivo or loading hepatocytes in vitro with exogenous commensal lipid antigens augments the hepatic γδT-17 cell number. Moreover, the microbiota accelerate nonalcoholic fatty liver disease through hepatic γδT-17 cells. Thus, our work describes a unique liver-resident γδT-17 cell subset maintained by gut commensal microbes through CD1d/lipid antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans and mice, NASH is associated with type 3 inflammation, characterized by the by the production of the cytokine IL-17A, most notably by mucosal-associated invariant T (MAIT) cells and γδ T cells (11)(12)(13).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
The maternal microbiota drives early postnatal innate immune development
Gomez de Agüero, M., Ganal-Vonarburg, S. C., Fuhrer, T., Rupp, S., Uchimura, Y., Li, H., Steinert, A., Heikenwalder, M., Hapfelmeier, S., Sauer, U., et al. (2016) · Science · doi:10.1126/science.aad2571 · Cited by 1,231
Compartmentalized Control of Skin Immunity by Resident Commensals
Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M. J., Salcedo, R., Kastenmuller, W., Deming, C., Quinones, M., Koo, L., Conlan, S., et al. (2012) · Science · doi:10.1126/science.1225152 · Cited by 1,092
Immune surveillance by the liver
Jenne, C. N., & Kubes, P. (2013) · Nature Immunology · doi:10.1038/ni.2691 · Cited by 1,047
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Bonneville, M., O'Brien, R. L., & Born, W. K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2781 · Cited by 952
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
Self-citation
Cited by
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552
Homeostatic Immunity and the Microbiota
Belkaid, Y., & Harrison, O. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.008 · Cited by 1,261
“A recent report also links the ability of the microbiota to maintain the homeostasis of liver-resident γδT-17 cells via lipid antigen/CD1d-dependent pathways (Li et al., 2017).”
Kennedy, E. A., King, K. Y., & Baldridge, M. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01534 · Cited by 602
“In parallel with this decrease in inflammatory cytokines, some reports suggest that there is an increase in the expression of Th2 family cytokines such as IL-4, IL-5, and IL-13, especially after allergen exposure, consistent with a shift from Th1 to Th2-type immunity after microbiota depletion (Hill et al., 2010; Suár…”
BackgroundInfluentialImmune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
γδ T cells in tissue physiology and surveillance
Ribot, J. C., Lopes, N., & Silva-Santos, B. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00452-4 · Cited by 532
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Ruf, B., Heinrich, B., & Greten, T. F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00572-w · Cited by 312
IL-17+ γδ T cells as kick-starters of inflammation
Papotto, P. H., Ribot, J. C., & Silva-Santos, B. (2017) · Nature Immunology · doi:10.1038/ni.3726 · Cited by 304
Dupraz, L., Magniez, A., Rolhion, N., Richard, M. L., Da Costa, G., Touch, S., Mayeur, C., Planchais, J., Agus, A., Danne, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109332 · Cited by 274
Cui, H., Cai, Y., Wang, L., Jia, B., Li, J., Zhao, S., Chu, X., Lin, J., Zhang, X., Bian, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00571 · Cited by 240
“The DNA in stools was quantified as previously described (Li et al., 2017).”
MethodThe Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
Van Herck, M. A., Weyler, J., Kwanten, W. J., Dirinck, E. L., De Winter, B. Y., Francque, S. M., & Vonghia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00082 · Cited by 238
The microbiome and autoimmunity: a paradigm from the gut–liver axis
Li, B., Selmi, C., Tang, R., Gershwin, M. E., & Ma, X. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2018.7 · Cited by 229
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies
Bokoliya, S. C., Dorsett, Y., Panier, H., & Zhou, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.711055 · Cited by 185
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Yabut, J. M., & Drucker, D. J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac018 · Cited by 175
The Impact of the Microbiome on Immunity to Vaccination in Humans
de Jong, S. E., Olin, A., & Pulendran, B. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.014 · Cited by 160
Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells
Khairallah, C. F., Chu, T. H., & Sheridan, B. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02636 · Cited by 151
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Gao, Z., Bai, Y., Lin, A., Jiang, A., Zhou, C., Cheng, Q., Liu, Z., Chen, X., Zhang, J., & Luo, P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01722-0 · Cited by 138
The role of gut microbiota in T cell immunity and immune mediated disorders
Shim, J. A., Ryu, J. H., Jo, Y., & Hong, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79430 · Cited by 153
“Commensal microbiota affects γδ T17 cell activation and IL-17 cytokine secretion, which accelerates non-alcoholic fatty liver disease (NAFLD) progression [74].”
The gut microbiota promotes distal tissue regeneration via RORγ+ regulatory T cell emissaries
Hanna, B. S., Wang, G., Galván-Peña, S., Mann, A. O., Ramirez, R. N., Muñoz-Rojas, A. R., Smith, K., Wan, M., Benoist, C., & Mathis, D. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.033 · Cited by 126
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Barrow, F., Khan, S., Wang, H., & Revelo, X. S. (2021) · Hepatology · doi:10.1002/hep.31889 · Cited by 126
γδ T cell responses: How many ligands will it take till we know?
Vermijlen, D., Gatti, D., Kouzeli, A., Rus, T., & Eberl, M. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.10.009 · Cited by 125
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Tirelle, P., Breton, J., Riou, G., Déchelotte, P., Coëffier, M., & Ribet, D. (2020) · BMC Microbiology · doi:10.1186/s12866-020-02018-9 · Cited by 123
CD4+ T cell activation and inflammation in NASH-related fibrosis
Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967410 · Cited by 106
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
Yang, X., Lu, D., Zhuo, J., Lin, Z., Yang, M., & Xu, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46405 · Cited by 119
Han, Y., Ling, Q., Wu, L. M., Wang, X., Wang, Z., Chen, J., Zheng, Z., Zhou, Z., Jia, L., Li, L., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221485 · Cited by 116
Psoriasis and Systemic Inflammatory Disorders
Tashiro, T., & Sawada, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084457 · Cited by 104
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
Kuchay, M. S., Choudhary, N. S., & Ramos‐Molina, B. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00951.2024 · Cited by 115
The Roles of Liver-Resident Lymphocytes in Liver Diseases
Wang, Y., & Zhang, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01582 · Cited by 86
Immune surveillance of the liver by T cells
Ficht, X., & Iannacone, M. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba2351 · Cited by 88
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Chen, Y., & Tian, Z. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00561-z · Cited by 102
Self-citationGut microbiota and systemic immunity in health and disease
Lo, B. C., Chen, G., Núñez, G., & Caruso, R. (2020) · International Immunology · doi:10.1093/intimm/dxaa079 · Cited by 93
From thymus to periphery: Molecular basis of effector γδ‐T cell differentiation
Fiala, G. J., Gomes, A. Q., & Silva‐Santos, B. (2020) · Immunological Reviews · doi:10.1111/imr.12918 · Cited by 91
Crosstalk between γδ T cells and the microbiota
Papotto, P., Yilmaz, B., & Silva-Santos, B. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00948-2 · Cited by 76
The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis
Mladenić, K., Lenartić, M., Marinović, S., Polić, B., & Wensveen, F. M. (2024) · European Journal of Immunology · doi:10.1002/eji.202149641 · Cited by 98
γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Torres‐Hernandez, A., Wang, W., Nikiforov, Y., Tejada, K., Torres, L., Kalabin, A., Adam, S., Wu, J., Lu, L., Chen, R., et al. (2020) · Hepatology · doi:10.1002/hep.30952 · Cited by 80
Gut microbiota mediated T cells regulation and autoimmune diseases
Bhutta, N. K., Xu, X., Jian, C., Wang, Y., Liu, Y., Sun, J., Han, B., Wu, S., & Javeed, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1477187 · Cited by 81
Fan, X., Mai, C.-T., Zuo, L., Huang, J., Xie, C., Jiang, Z., Li, R., Yao, X., Fan, X., Wu, Q., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.10.016 · Cited by 79
Forsberg, M. M., Björkander, S., Pang, Y., Lundqvist, L., Ndi, M., Ott, M., Escribá, I. B., Jaeger, M.-C., Roos, S., & Sverremark‐Ekström, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-53576-6 · Cited by 79
Hirsova, P., Bamidele, A. O., Wang, H., Povero, D., & Revelo, X. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.760860 · Cited by 74
“In mice, the microbiota appears to control the number of hepatic-resident gd T cells and their homeostasis in a lipid antigen-CD1d-dependent manner (98).”
BackgroundResultInfluentialTian, P., Yang, W., Guo, X., Wang, T., Tan, S., Sun, R., Xiao, R., Wang, Y., Jiao, D., Xu, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37419-7 · Cited by 76
Self-citationCasting a wider net: Immunosurveillance by nonclassical MHC molecules
D’Souza, M. P., Adams, E. J., Altman, J. D., Birnbaum, M. E., Boggiano, C., Casorati, G., Chien, Y., Conley, A. P., Eckle, S. B. G., Früh, K., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007567 · Cited by 70
“γδ T cells are the major initial source of IL-17 production in mouse models of infection and autoimmune diseases, acting within hours of infectious challenge, likely triggered by very early cytokine responses [36, 37].”
BackgroundLiu, M., Hu, Y., Yuan, Y., Tian, Z., & Zhang, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00477 · Cited by 65
Self-citationLi, Y., Wang, Y., Shi, F., Zhang, X., Zhang, Y., Bi, K., Chen, X., Li, L., & Diao, H. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2096994 · Cited by 63
The microbiome and immune memory formation
McCoy, K. D., Burkhard, R., & Geuking, M. B. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12273 · Cited by 65
Gut Microbiota and IL-17A: Physiological and Pathological Responses
Douzandeh-Mobarrez, B., & Kariminik, A. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9329-z · Cited by 71
Bruni, E., Cimino, M. M., Donadon, M., Carriero, R., Terzoli, S., Piazza, R., Ravens, S., Prinz, I., Cazzetta, V., Marzano, P., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004579 · Cited by 57
Treating inflammation to combat non-alcoholic fatty liver disease
Wiering, L., & Tacke, F. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0194 · Cited by 56
Monin, L., Ushakov, D. S., Arnesen, H., Bah, N. K., Jandke, A., Muñoz‐Ruiz, M., Carvalho, J., Joseph, S., Almeida, B., Green, M. J., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0305-7 · Cited by 61
Interactions between the microbiota and innate and innate-like lymphocytes
Constantinides, M. G. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ri0917-378r · Cited by 58
Wong, A. M., Ding, X., Wong, A. M. G., Xu, M., Zhang, L., Leung, H. H. W., Chan, A. W. H., Song, Q. X., Kwong, J., Chan, L. K., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.015 · Cited by 63
Hu, Y., Peng, J., Li, F., Wong, F. S., & Li, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-33571-z · Cited by 57
Self-citationNAFLD, Helicobacter species and the intestinal microbiome
Castaño‐Rodríguez, N., Mitchell, H. M., & Kaakoush, N. O. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.008 · Cited by 55
Li, M., Wang, B., Sun, X., Tang, Y., Wei, X., Ge, B.-Y., Tang, Y., Deng, Y., He, C., Yuan, J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00824 · Cited by 57
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Torre, P., Motta, B. M., Sciorio, R., Masarone, M., & Persico, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.781567 · Cited by 53
“Moreover, the gut microbiota showed to support disease progression by γδ-T IL17+ cells (216).”
BackgroundThe liver as an immunological barrier redefined by single‐cell analysis
Stamataki, Z., & Swadling, L. (2020) · Immunology · doi:10.1111/imm.13193 · Cited by 46
Jensen, B. A. H., Holm, J. B., Larsen, I., von Burg, N., Derer, S., Sonne, S. B., Pærregaard, S. I., Damgaard, M. V., Indrelid, S., Rivollier, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21408-9 · Cited by 53
Gamma/Delta T Cells and Their Role in Protection Against Malaria
Deroost, K., & Langhorne, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02973 · Cited by 47
Denny, J. E., Powers, J. B., Castro, H. F., Zhang, J., Joshi‐Barve, S., Campagna, S. R., & Schmidt, N. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-40266-6 · Cited by 57
Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis
Chen, Y., & Tian, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01500 · Cited by 42
Self-citationIL-17A–producing γδT cells promote muscle regeneration in a microbiota-dependent manner
Mann, A. O., Hanna, B. S., Muñoz-Rojas, A. R., Sandrock, I., Prinz, I., Benoist, C. O., & Mathis, D. J. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211504 · Cited by 50
“Accrual of γδT cells and their enhanced IL-17A levels after muscle injury are microbiota dependent Previous reports have identified a role for the microbiota in inducing IL-17A–producing γδT cells (Duan et al., 2010; Ismail et al., 2011; Li et al., 2017; Jin et al., 2019; Wilharm et al., 2019).”
BackgroundStress kinases in the development of liver steatosis and hepatocellular carcinoma
Cicuéndez, B., Ruiz-Garrido, I., Mora, A., & Sabio, G. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101190 · Cited by 48
“Moreover, gd T cell-deficient mice have reduced levels of hepatic inflammation, transaminase, and insulin resistance [143].”
BackgroundWang, X., Lin, X., Zheng, Z., Lu, B., Jun, W., Tan, A. H., Zhao, M., Loh, J. T., Ng, S. W., Chen, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22242-9 · Cited by 47
Tissue-Resident Memory T Cells in the Liver—Unique Characteristics of Local Specialists
Bartsch, L. M., Damasio, M. P. S., Subudhi, S., & Drescher, H. K. (2020) · Cells · doi:10.3390/cells9112457 · Cited by 45
Marinović, S., Lenartić, M., Mladenić, K., Šestan, M., Kavazović, I., Benić, A., Krapić, M., Rindlisbacher, L., Cokarić Brdovčak, M., Sparano, C., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add1599 · Cited by 43
“IL-17Awas shown to directly activate HSCs in a mouse model of NASH (13).”
BackgroundInfluentialWang, X., & Tian, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0584-x · Cited by 44
Self-citationGut γδ T cells as guardians, disruptors, and instigators of cancer
Suzuki, T., Hayman, L., Kilbey, A., Edwards, J., & Coffelt, S. B. (2020) · Immunological Reviews · doi:10.1111/imr.12916 · Cited by 45
T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Gebru, Y. A., Gupta, H., Kim, H. S., Eom, J. A., Kwon, G.-H., Park, E., Jeong, J., Won, S., Sharma, S. P., Ganesan, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212190 · Cited by 43
Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease
Trejo, A. M. C., Větvička, V., Vištějnová, L., Králíčková, M., & Montúfar, E. B. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1887730 · Cited by 43
Abdelnabi, M. N., Hassan, G. S., & Shoukry, N. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437046 · Cited by 46
Wilharm, A., Brigas, H. C., Sandrock, I., Ribeiro, M. A., Amado, T., Reinhardt, A., Demera, A., Hoenicke, L., Strowig, T., Carvalho, T., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0330-6 · Cited by 45
Human Gut Microbiome and Liver Diseases: From Correlation to Causation
Li, R., Mao, Z., Ye, X., & Zuo, T. (2021) · Microorganisms · doi:10.3390/microorganisms9051017 · Cited by 42
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Yan, M., Man, S., Ma, L., Guo, L., Huang, L., & Gao, W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0315 · Cited by 44
Chen, B., Ni, X., Sun, R., Zeng, B., Wei, H., Tian, Z., & Wei, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01065 · Cited by 39
Self-citationRegulation of systemic metabolism by tissue-resident immune cell circuits
Li, J. H., Hepworth, M. R., & O’Sullivan, T. E. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.001 · Cited by 39
Innate-like T cells in liver disease
Yang, A. Y.-P., Wistuba‐Hamprecht, K., Greten, T. F., & Ruf, B. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.05.008 · Cited by 39
Gut-liver axis: gut microbiota in shaping hepatic innate immunity
Wu, X., & Tian, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9128-3 · Cited by 37
Self-citationWu, L. M., Han, Y., Zheng, Z., Zhu, S., Chen, J., Yao, Y., Yue, S., Teufel, A., Weng, H., Li, L., et al. (2021) · Nutrients · doi:10.3390/nu13030940 · Cited by 40
“1 g/L fructose) in drinking water) [21] for nine weeks to induce MDs and 12 mice were fed with normal chow.”
MethodDouble-edged sword: γδ T cells in mucosal homeostasis and disease
Kang, I., Kim, Y., & Lee, H. K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00985-3 · Cited by 42
Tian, K., Jing, D., Lan, J., Lv, M., & Wang, T. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1316 · Cited by 45
Role of γδT cells in liver diseases and its relationship with intestinal microbiota
Zhou, Q., Wu, F., Pang, L., Zhang, T., & Chen, Z. J. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i20.2559 · Cited by 36
Innate immunity and early liver inflammation
Zhou, J. Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175147 · Cited by 40
Hu, Y., Fang, K., Wang, Y., Lü, N., Sun, H., & Zhang, C. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00656-1 · Cited by 34
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
Santos‐Laso, Á., Gutiérrez‐Larrañaga, M., Alonso‐Peña, M., Medina, J. M., Iruzubieta, P., Arias, M., López‐Hoyos, M., & Crespo, J. (2021) · Biomedicines · doi:10.3390/biomedicines10010046 · Cited by 40
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC
Wu, Q., Yang, Y., Lin, S., Geller, D. A., & Yan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1569915 · Cited by 32
Zhang, Y., Jiang, W., Xu, J., Wu, N., Wang, Y., Lin, T., Liu, Y., & Liu, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.535940 · Cited by 33
“Furthermore, it has been reported that Escherichia is a unique genus that is significantly elevated in NASH patients compared with healthy controls and obese patients (Li et al., 2017).”
BackgroundGut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions
Zhao, Q., Wu, J., Ding, Y., Pang, Y., & Jiang, C. (2023) · Life Metabolism · doi:10.1093/lifemeta/load032 · Cited by 35
The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
Won, S., Park, E., Jeong, J., Ganesan, R., Gupta, H., Gebru, Y. A., Sharma, S., Kim, D. J., & Suk, K. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158309 · Cited by 33
“It has been reported that substances derived from the gut microbiota affect the maturation of hepatic natural killer (NK) cells and the maintenance of the homeostasis of hepatic interleukin (IL)-17A-producing γδ T cells [33,34].”
BackgroundLiu, Y., Hao, Y., Boeckmans, J., Rodrigues, R. M., & He, Y. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108353 · Cited by 31
Zhang, P., Liu, N., Xue, M., Zhang, M., Xiao, Z., Xu, C., Fan, Y., Qiu, J., Zhang, Q., & Zhou, Y. K. (2024) · Animals · doi:10.3390/ani14091289 · Cited by 30
“Total RNA was extracted using TRIzol reagent [40].”
MethodWilharm, A., Brigas, H. C., Sandrock, I., Ribeiro, M. A., Amado, T., Reinhardt, A., Demera, A., Hoenicke, L., Strowig, T., Carvalho, T., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00346-7 · Cited by 30
Çebi, M., & Yilmaz, Y. N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1445634 · Cited by 30
Crucial role of T cells in NAFLD-related disease: A review and prospect
Mao, T., Yang, R. X., Luo, Y., & He, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1051076 · Cited by 33
The Emerging Complexity of γδT17 Cells
McKenzie, D. R., Comerford, I., Silva‐Santos, B., & McColl, S. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00796 · Cited by 29
Lee, J. J., Lee, S. M., & Jung, J. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153354 · Cited by 29
Golonka, R. M., & Vijay–Kumar, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.004 · Cited by 29
Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis
Wan, M., Han, J., Ding, L., Hu, F., & Gao, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.604894 · Cited by 30
Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
Taitz, J., Tan, J., Ni, D., Potier‐Villette, C., Grau, G. E., Nanan, R. K. H., & Macia, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1493991 · Cited by 36
Liu, J., Ding, M., Bai, J., Luo, R., Liu, R., Qu, J., & Li, X. (2023) · iMeta · doi:10.1002/imt2.76 · Cited by 25
Metadata
- Authors
- Li, F., Hao, X., Chen, Y., Bai, L., Gao, X., Lian, Z., Wei, H., Sun, R., & Tian, Z.
- Affiliations
- University of Science and Technology of China (CN)
- Model Animal Research Center (CN)
- Corresponding author
- Tian, Zhigang
- Venue
- Nature Communications
- Published
- 2017-01-09
- Volume
- 8
- Issue
- 1
- Pages
- 13839-13839
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5227332
- OpenAlex
- W2571062870
- Cited by
- 191
- References
- 60
- Citations by year
- 2026: 8 · 2025: 26 · 2024: 20 · 2023: 23 · 2022: 23 · 2021: 27 · 2020: 28 · 2019: 14 · 2018: 14 · 2017: 8
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-04-06)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31230025, 91429303)
- China Postdoctoral Science Foundation
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- gut microbiota, CD1d, lipid antigen presentation, IL-17A, hepatocytes, Escherichia coli, non-alcoholic fatty liver disease, regional immunity, commensal bacteria, T cell homeostasis
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cells, Cultured, Escherichia coli, Liver, Lymphocyte Activation, Male, Mice, Inbred C57BL, Receptors, Antigen, T-Cell, gamma-delta, Mice, Knockout, Interleukin-17, Hepatocytes, Mice, Antigens, CD1d, Th17 Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.